Company Filing History:
Years Active: 2016-2017
Title: Sanjay Kumar Banerjee: Innovator in Pharmaceutical Chemistry
Introduction
Sanjay Kumar Banerjee is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as potential therapeutic agents. With a total of 4 patents to his name, Banerjee's work focuses on innovative solutions for various medical conditions.
Latest Patents
One of his latest patents is titled "Process for preparation of indolizine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors." This invention provides compounds of general formula 1 that are useful as potential PDE3 inhibitory agents. The derivatives can be employed as therapeutics in both human and veterinary medicine, targeting diseases such as heart failure, dilated cardiomyopathy, platelet inhibitors, cancer, and obstructive pulmonary diseases.
Another notable patent is "Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof." Similar to his previous work, this invention also provides compounds of formula 1 as potential PDE3 inhibitory agents. These derivatives can be utilized in the treatment and prophylaxis of various medical conditions, including heart failure and cancer.
Career Highlights
Sanjay Kumar Banerjee is currently associated with the Council of Scientific and Industrial Research, where he continues to advance his research in pharmaceutical chemistry. His innovative work has garnered attention in the scientific community, contributing to the development of new therapeutic agents.
Collaborations
Banerjee has collaborated with notable colleagues, including Budde Mahendar and Saidulu Mattapally, to further enhance his research efforts and expand the impact of his inventions.
Conclusion
Sanjay Kumar Banerjee's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health issues but also showcases the potential of chemical compounds in therapeutic applications.